Annual EBIT
-$6.48 M
+$94.85 M+93.60%
December 31, 2023
Summary
- As of February 7, 2025, CTMX annual earnings before interest & taxes is -$6.48 million, with the most recent change of +$94.85 million (+93.60%) on December 31, 2023.
- During the last 3 years, CTMX annual EBIT has risen by +$74.06 million (+91.95%).
- CTMX annual EBIT is now at all-time high.
Performance
CTMX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
$4.11 M
+$12.56 M+148.64%
September 30, 2024
Summary
- As of February 7, 2025, CTMX quarterly earnings before interest & taxes is $4.11 million, with the most recent change of +$12.56 million (+148.64%) on September 30, 2024.
- Over the past year, CTMX quarterly EBIT has increased by +$988.00 thousand (+31.64%).
- CTMX quarterly EBIT is now -64.73% below its all-time high of $11.66 million, reached on March 31, 2024.
Performance
CTMX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
$6.71 M
+$988.00 K+17.27%
September 30, 2024
Summary
- As of February 7, 2025, CTMX TTM earnings before interest & taxes is $6.71 million, with the most recent change of +$988.00 thousand (+17.27%) on September 30, 2024.
- Over the past year, CTMX TTM EBIT has increased by +$22.10 million (+143.61%).
- CTMX TTM EBIT is now -38.02% below its all-time high of $10.83 million, reached on March 31, 2024.
Performance
CTMX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CTMX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +93.6% | +31.6% | +143.6% |
| 3 y3 years | +92.0% | +31.6% | +143.6% |
| 5 y5 years | +91.7% | +31.6% | +143.6% |
CTMX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +94.4% | -64.7% | +107.0% | -38.0% | +104.5% |
| 5 y | 5-year | at high | +95.4% | -64.7% | +106.0% | -38.0% | +104.5% |
| alltime | all time | at high | +95.4% | -64.7% | +106.0% | -38.0% | +104.5% |
CytomX Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $4.11 M(-148.6%) | $6.71 M(+17.3%) |
| Jun 2024 | - | -$8.45 M(-172.5%) | $5.72 M(-47.1%) |
| Mar 2024 | - | $11.66 M(-2023.6%) | $10.83 M(-267.0%) |
| Dec 2023 | -$6.48 M(-93.6%) | -$606.00 K(-119.4%) | -$6.48 M(-57.9%) |
| Sep 2023 | - | $3.12 M(-193.3%) | -$15.39 M(-68.1%) |
| Jun 2023 | - | -$3.35 M(-40.8%) | -$48.22 M(-35.6%) |
| Mar 2023 | - | -$5.65 M(-40.5%) | -$74.92 M(-26.1%) |
| Dec 2022 | -$101.33 M(-12.7%) | -$9.51 M(-68.0%) | -$101.33 M(-32.6%) |
| Sep 2022 | - | -$29.71 M(-1.1%) | -$150.40 M(+4.9%) |
| Jun 2022 | - | -$30.05 M(-6.3%) | -$143.33 M(+8.2%) |
| Mar 2022 | - | -$32.06 M(-45.3%) | -$132.48 M(+14.2%) |
| Dec 2021 | -$116.04 M(+44.1%) | -$58.57 M(+158.7%) | -$116.04 M(+11.4%) |
| Sep 2021 | - | -$22.64 M(+17.9%) | -$104.19 M(+8.0%) |
| Jun 2021 | - | -$19.20 M(+22.9%) | -$96.44 M(+3.3%) |
| Mar 2021 | - | -$15.63 M(-66.5%) | -$93.37 M(+15.9%) |
| Dec 2020 | -$80.54 M(-43.1%) | -$46.71 M(+213.6%) | -$80.54 M(-20.9%) |
| Sep 2020 | - | -$14.89 M(-7.7%) | -$101.79 M(-9.6%) |
| Jun 2020 | - | -$16.14 M(+477.8%) | -$112.61 M(-11.8%) |
| Mar 2020 | - | -$2.79 M(-95.9%) | -$127.71 M(-9.7%) |
| Dec 2019 | -$141.48 M | -$67.97 M(+164.3%) | -$141.48 M(+42.4%) |
| Sep 2019 | - | -$25.72 M(-17.7%) | -$99.33 M(+2.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$31.23 M(+88.5%) | -$96.78 M(+22.8%) |
| Mar 2019 | - | -$16.57 M(-35.8%) | -$78.81 M(+1.2%) |
| Dec 2018 | -$77.87 M(+78.6%) | -$25.81 M(+11.4%) | -$77.87 M(+53.7%) |
| Sep 2018 | - | -$23.18 M(+74.8%) | -$50.66 M(+31.6%) |
| Jun 2018 | - | -$13.26 M(-15.2%) | -$38.51 M(-23.9%) |
| Mar 2018 | - | -$15.63 M(-1216.4%) | -$50.63 M(+16.1%) |
| Dec 2017 | -$43.61 M(-26.0%) | $1.40 M(-112.7%) | -$43.61 M(-25.5%) |
| Sep 2017 | - | -$11.03 M(-56.5%) | -$58.58 M(-6.2%) |
| Jun 2017 | - | -$25.37 M(+194.6%) | -$62.47 M(+21.6%) |
| Mar 2017 | - | -$8.61 M(-36.5%) | -$51.35 M(-12.1%) |
| Dec 2016 | -$58.92 M(+75.2%) | -$13.56 M(-9.1%) | -$58.41 M(+4.4%) |
| Sep 2016 | - | -$14.92 M(+4.6%) | -$55.96 M(+7.2%) |
| Jun 2016 | - | -$14.26 M(-9.0%) | -$52.19 M(+20.5%) |
| Mar 2016 | - | -$15.67 M(+41.1%) | -$43.32 M(+28.8%) |
| Dec 2015 | -$33.63 M(+12.8%) | -$11.11 M(-0.4%) | -$33.63 M(+23.7%) |
| Sep 2015 | - | -$11.15 M(+106.7%) | -$27.19 M(+39.3%) |
| Jun 2015 | - | -$5.39 M(-9.8%) | -$19.51 M(+38.2%) |
| Mar 2015 | - | -$5.98 M(+28.1%) | -$14.12 M(+73.5%) |
| Dec 2014 | -$29.81 M(+100.4%) | -$4.67 M(+34.4%) | -$8.14 M(+134.4%) |
| Sep 2014 | - | -$3.47 M | -$3.47 M |
| Dec 2013 | -$14.88 M | - | - |
FAQ
- What is CytomX Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for CytomX Therapeutics?
- What is CytomX Therapeutics annual EBIT year-on-year change?
- What is CytomX Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for CytomX Therapeutics?
- What is CytomX Therapeutics quarterly EBIT year-on-year change?
- What is CytomX Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for CytomX Therapeutics?
- What is CytomX Therapeutics TTM EBIT year-on-year change?
What is CytomX Therapeutics annual earnings before interest & taxes?
The current annual EBIT of CTMX is -$6.48 M
What is the all time high annual EBIT for CytomX Therapeutics?
CytomX Therapeutics all-time high annual earnings before interest & taxes is -$6.48 M
What is CytomX Therapeutics annual EBIT year-on-year change?
Over the past year, CTMX annual earnings before interest & taxes has changed by +$94.85 M (+93.60%)
What is CytomX Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of CTMX is $4.11 M
What is the all time high quarterly EBIT for CytomX Therapeutics?
CytomX Therapeutics all-time high quarterly earnings before interest & taxes is $11.66 M
What is CytomX Therapeutics quarterly EBIT year-on-year change?
Over the past year, CTMX quarterly earnings before interest & taxes has changed by +$988.00 K (+31.64%)
What is CytomX Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of CTMX is $6.71 M
What is the all time high TTM EBIT for CytomX Therapeutics?
CytomX Therapeutics all-time high TTM earnings before interest & taxes is $10.83 M
What is CytomX Therapeutics TTM EBIT year-on-year change?
Over the past year, CTMX TTM earnings before interest & taxes has changed by +$22.10 M (+143.61%)